|
1
|
Lee SY, Jeong EK, Ju MK, Jeon HM, Kim MY,
Kim CH, Park HG, Han SI and Kang HS: Induction of metastasis,
cancer stem cell phenotype, and oncogenic metabolism in cancer
cells by ionizing radiation. Mol Cancer. 16:102017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hara T, Iwadate M, Tachibana K, Waguri S,
Takenoshita S and Hamada N: Metastasis of breast cancer cells to
the bone, lung, and lymph nodes promotes resistance to ionizing
radiation. Strahlenther Onkol. 193:848–855. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kuwahara Y, Mori M, Kitahara S and
Fukumoto M, Ezaki T, Mori S, Echigo S, Ohkubo Y and Fukumoto M:
Targeting of tumor endothelial cells combining 2 Gy/day of X-ray
with Everolimus is the effective modality for overcoming clinically
relevant radioresistant tumors. Cancer Med. 3:310–321. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim JS, Chang JW, Yun HS, Yang KM, Hong
EH, Kim DH, Um HD, Lee KH, Lee SJ and Hwang SG: Chloride
intracellular channel 1 identified using proteomic analysis plays
an important role in the radiosensitivity of HEp-2 cells via
reactive oxygen species production. Proteomics. 10:2589–2604. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hazawa M, Hosokawa Y, Monzen S, Yoshino H
and Kashiwakura I: Regulation of DNA damage response and cell cycle
in radiation-resistant HL60 myeloid leukemia cells. Oncol Rep.
28:55–61. 2012.PubMed/NCBI
|
|
6
|
Arechaga-Ocampo E, Lopez-Camarillo C,
Villegas-Sepulveda N, Gonzalez-De la Rosa CH, Perez-Añorve IX,
Roldan-Perez R, Flores-Perez A, Peña-Curiel O, Angeles-Zaragoza O,
Rangel Corona R, et al: Tumor suppressor miR-29c regulates
radioresistance in lung cancer cells. Tumor Biol.
39:10104283176950102017. View Article : Google Scholar
|
|
7
|
Zhou SB, Guo XW, Gu L and Ji SJ:
Influential factors on radiotherapy efficacy and prognosis in
patients with secondary lymph node metastasis after esophagectomy
of thoracic esophageal squamous cell carcinoma. Cancer Manag Res.
10:217–225. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang J, Xu H, Guo X, Zhang J, Ye X, Yang Y
and Ma X: Pretreatment inflammatory indexes as prognostic
predictors for survival in colorectal cancer patients receiving
neoadjuvant chemoradiotherapy. Sci Rep. 8:30442018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Matsuda T, Sumi Y, Yamashita K, Hasegawa
H, Yamamoto M, Matsuda Y, Kanaji S, Oshikiri T, Nakamura T, Suzuki
S and Kakeji Y: Outcomes and prognostic factors of selective
lateral pelvic lymph node dissection with preoperative
chemoradiotherapy for locally advanced rectal cancer. Int J
Colorectal Dis. 33:367–374. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xia Y, Li YH, Chen Y, Liu Q, Zhang JH,
Deng JY, Ai TS, Zhu HT, Badakhshi H and Zhao KL: A phase II trial
of concurrent chemoradiotherapy with weekly paclitaxel and
carboplatin in advanced oesophageal carcinoma. Int J Clin Oncol.
23:458–465. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fangzheng W, Chuner J, Quanquan S, Zhimin
Y, Tongxin L, Jiping L, Sakamoto M, Peng W, Kaiyuan S, Weifeng Q,
et al: Addition of 5-fluorouracil to docetaxel/cisplatin does not
improve survival in locoregionally advanced nasopharyngeal
carcinoma. Oncotarget. 8:115469–115479. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim HJ, Choi GS, Park JS, Park SY, Cho SH,
Lee SJ, Kang BW and Kim JG: Optimal treatment strategies for
clinically suspicious lateral pelvic lymph node metastasis in
rectal cancer. Oncotarget. 8:100724–100733. 2017.PubMed/NCBI
|
|
13
|
Nakamura T, Takagaki K, Shibata S, Tanaka
K, Higuchi T and Endo M: Hyaluronic-acid-deficient extracellular
matrix induced by addition of 4-methylumbelliferone to the medium
of cultured human skin fibroblasts. Biochem Biophys Res Commun.
208:470–475. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kuroda Y, Kasai K, Nanashima N, Nozaka H,
Nakano M, Chiba M, Yoneda M and Nakamura T: 4-Methylumbelliferone
inhibits the phosphorylation of hyaluronan synthase 2 induced by
12-O-tetradecanoyl-phorbol-13-acetate. Biomed Res. 34:97–103. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yates TJ, Lopez LE, Lokeshwar SD, Ortiz N,
Kallifatidis G, Jordan A, Hoye K, Altman N and Lokeshwar VB:
Dietary supplement 4-methylumbelliferone: An effective
chemopreventive and therapeutic agent for prostate cancer. J Natl
Cancer Inst. 107(djv085)2015.PubMed/NCBI
|
|
16
|
Piccioni F, Fiore E, Bayo J, Atorrasagasti
C, Peixoto E, Rizzo M, Malvicini M, Tirado-González I, García MG,
Alaniz L and Mazzolini G: 4-methylumbelliferone inhibits
hepatocellular carcinoma growth by decreasing IL-6 production and
angiogenesis. Glycobiology. 25:825–835. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li F, Hao P, Liu G, Wang W, Han R, Jiang Z
and Li X: Effects of 4-methylumbelliferone and high molecular
weight hyaluronic acid on the inflammation of corneal stromal cells
induced by LPS. Graefes Arch Clin Exp Ophthalmol. 255:559–566.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Piao L, Canguo Z, Wenjie L, Xiaoli C,
Wenli S and Li L: Lipopolysaccharides-stimulated macrophage
products enhance Withaferin A-induced apoptosis via activation of
caspases and inhibition of NF-κB pathway in human cancer cells. Mol
Immunol. 81:92–101. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yu H, Aravindan N, Xu J and Natarajan M:
Inter- and intra-cellular mechanism of NF-kB-dependent survival
advantage and clonal expansion of radio-resistant cancer cells.
Cell Signal. 31:105–111. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mochizuki D, Adams A, Warner KA, Zhang Z,
Pearson AT, Misawa K, McLean SA, Wolf GT and Nör JE: Anti-tumor
effect of inhibition of IL-6 signaling in mucoepidermoid carcinoma.
Oncotarget. 6:22822–22835. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee SO, Yang X, Duan S, Tsai Y, Strojny
LR, Keng P and Chen Y: IL-6 promotes growth and
epithelial-mesenchymal transition of CD133+ cells of non-small cell
lung cancer. Oncotarget. 7:6626–6638. 2016.PubMed/NCBI
|
|
22
|
Saga R, Monzen S, Chiba M, Yoshino H,
Nakamura T and Hosokawa Y: Anti-tumor and anti-invasion effects of
a combination of 4-methylumbelliferone and ionizing radiation in
human fibrosarcoma cells. Oncol Lett. 13:410–416. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lokeshwar VB, Lopez LE, Munoz D, Chi A,
Shirodkar SP, Lokeshwar SD, Escudero DO, Dhir N and Altman N:
Antitumor activity of hyaluronic acid synthesis inhibitor
4-methylumbelliferone in prostate cancer cells. Cancer Res.
70:2613–2623. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Arai E, Nishida Y, Wasa J, Urakawa H, Zhuo
L, Kimata K, Kozawa E, Futamura N and Ishiguro N: Inhibition of
hyaluronan retention by 4-methylumbelliferone suppresses
osteosarcoma cells in vitro and lung metastasis in vivo. Br J
Cancer. 105:1839–1849. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Urakawa H, Nishida Y, Wasa J, Arai E, Zhuo
L, Kimata K, Kozawa E, Futamura N and Ishiguro N: Inhibition of
hyaluronan synthesis in breast cancer cells by
4-methylumbelliferone suppresses tumorigenicity in vitro and
metastatic lesions of bone in vivo. Int J Cancer. 130:454–466.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li Y, Li L, Brown TJ and Heldin P:
Silencing of hyaluronan synthase 2 suppresses the malignant
phenotype of invasion breast cancer cells. Int J Cancer.
120:2557–2567. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nazarenko I, Marhaba R, Reich E, Voronov
E, Vitacolonna M, Hildebrand D, Elter E, Rajasagi M, Apte RN and
Zöller M: Tumorigenicity of IL-1alpha- and IL-1beta-deficient
fibrosarcoma cells. Neoplasia. 10:549–562. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sun Y and Ma L: The emerging molecular
machinery and therapeutic targets of metastasis. Trends Pharmacol
Sci. 36:349–359. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tamari Y, Kashino G and Mori H:
Acquisition of radioresistance by IL-6 treatment is caused by
suppression of oxidative stress derived from mitochondria after
γ-irradiation. J Radiat Res. 58:412–420. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen Y, Zhang F, Tsai Y, Yang X, Yang L,
Duan S, Wang X, Keng P and Lee SO: IL-6 signaling promotes DNA
repair and prevents apoptosis in CD133+ stem-like cells of lung
cancer after radiation. Radiat Oncol. 10:2272015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Duan S, Tsai Y, Keng P and Chen Y, Lee SO
and Chen Y: IL-6 signaling contributes to cisplatin resistance in
non-small cell lung cancer via the up-regulation of anti-apoptotic
and DNA repair associated molecules. Oncotarget. 6:27651–27660.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Stanam A, Gibson-Corley KN, Love-Homan L,
Ihejirika N and Simons AL: Interleukin-1 blockade overcomes
erlotinib resistance in head and neck squamous cell carcinoma.
Oncotarget. 7:76087–76100. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Grivennikov SI and Karin M: Dangerous
liaisons: STAT3 and NF-kappaB collaboration and crosstalk in
cancer. Cytokine Growth Factor Rev. 21:11–19. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hei TK, Zhou H, Chai Y, Ponnaiya B and
Ivanov VN: Radiation induced non-targeted response: Mechanism and
potential clinical implications. Curr Mol Pharmacol. 4:96–105.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Nagy N, Kuipers HF, Frymoyer AR, Ishak HD,
Bollyky JB, Wight TN and Bollyky PL: 4-methylumbelliferone
treatment and hyaluronan inhibition as a therapeutic strategy in
inflammation, autoimmunity, and cancer. Front Immunol. 6:1232015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hauser-Kawaguchi A, Luyt LG and Turley E:
Design of peptide mimetics to block pro-inflammatory functions of
HA fragments. Matrix Biol. S0945(053X): 30444–30454. 2018.
|
|
38
|
Xu Y, Kiningham KK, Devalaraja MN, Yeh CC,
Majima H, Kasarskis EJ and St Clair DK: An intronic NF-kappaB
element is essential for induction of the human manganese
superoxide dismutase gene by tumor necrosis factor-alpha and
interleukin-1beta. DNA Cell Biol. 18:709–722. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bajinskis A, Natarajan AT, Erixon K and
Harms-Ringdahl M: DNA double strand breaks induced by the indirect
effect of radiation are more efficiently repaired by non-homologous
end joining compared to homologous recombination repair. Mutat Res.
756:21–29. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Vignard J, Mirey G and Salles B:
Ionizing-radiation induced DNA double-strand breaks: A direct and
indirect lighting up. Radiother Oncol. 108:362–369. 2013.
View Article : Google Scholar : PubMed/NCBI
|
